Home › Funds › Elmind Capital, LP › ENGN

Elmind Capital, LP position in ENGN

ENGENE THERAPEUTICS INC · Health Care

Elmind Capital, LP reported holding 210,000 shares of ENGN (ENGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$363K, representing 0.09% of its reported portfolio and ranking #35 among its reported holdings. Elmind Capital, LP has disclosed ENGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

Latest position (Q2 2026)210.00K sh
Reported value held$363.30K
Portfolio Weight0.09%
First reportedQ4 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Elmind Capital, LP's ENGN position evolved

Elmind Capital, LP first disclosed a stake in ENGN in Q4 2025 at 210,000 shares (US$1.9M). Across 3 filings, Elmind Capital, LP held the position steady without any share-count change. The most recent filing (Q2 2026) shows 210,000 shares valued at US$363K.

Quarter by quarter

QuarterSharesValueChange
Q4 2025 210.00K $1.90M New
Q1 2026 210.00K $1.43M Hold
Q2 2026 210.00K $363.30K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ENGN and 13F data

ENGN (ENGENE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in ENGN — the largest reported positions include FCPM III SERVICES B.V. (US$16.7M), BML Capital Management, LLC (US$11.5M), Nextech Invest Ltd. (US$4.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ENGN

All ENGN fund holders →

FAQ

How long has Elmind Capital, LP held ENGN?

Elmind Capital, LP has disclosed ENGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.

What is Elmind Capital, LP's current position in ENGN?

As of Q2 2026, Elmind Capital, LP holds 210.00K shares of ENGN (ENGENE THERAPEUTICS INC), valued at $363.30K, representing 0.09% of its reported portfolio and ranking #35.

Has Elmind Capital, LP been buying or selling ENGN?

In the latest 13F filing (Q2 2026), Elmind Capital, LP held unchanged its position in ENGN.

Which other funds hold ENGN?

Other major institutional holders of ENGN include FCPM III SERVICES B.V., BML Capital Management, LLC, Nextech Invest Ltd., among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.